期刊文献+

恶性肿瘤患者深部感染主要病原菌的RAPD分析

Analysing on main pathogen of deep fungus infection in patients with maligant tumor by using RAPD
下载PDF
导出
摘要 目的对恶性肿瘤患者深部真菌感染的主要病原菌进行分子生物学水平研究,以探讨该种感染在发生发展过程中病原菌的变化及其与发病的关系。方法用随机扩增多态性DNA分析技术对恶性肿瘤患者深部真菌感染的主要病原菌基因进行分析。结果两条随机引物扩增的患者组和对照组白色念珠菌菌株之间条带的数量和片段大小存在差异,即使带型完全一致的菌株,有些片段的EB显色强度也有区别,但尚无统计学意义。结论恶性肿瘤患者深部真菌感染白色念珠菌的基因在疾病的发生、发展过程中基本稳定。 Objective To investigate the changes and pathogenicity of the main pathogen of deep fungus infection in patients with maligant tumor in molecular biology. Methods The genes of the main pathogen were analyzed by using Randomly Amplified Polymorphic DNA technique.Results The randomly amplified numbers of bands and the length of fragments of two-group strains were different. Even if the bands were identical, the fluorescence intensity was different. However, the diversity of genes of two-group strains had no statistical significance by χ2-test.Conclusion The genes of Candida albicans of clinic strains are stable in pathopoiesis procedure.
出处 《实用医药杂志》 2005年第6期540-542,共3页 Practical Journal of Medicine & Pharmacy
关键词 恶性肿瘤 深部真菌感染 白色念珠菌 随机扩增多态性DNA Malignant tumor Deep fungus infection Candida albicansRandomly Amplified Polymorphic DNA technique(RAPD)
  • 相关文献

参考文献6

二级参考文献17

  • 1[1] Beck SC, Jarvis WR. Secular trends in the epidemiology o f nosocomial fungal infections in the United States[J]. J Infect Dis, 1993,167 (5):1247-1251.
  • 2[3] Ghannoum MA, Rex JH, Galgiani JN. Susceptibility testing of fungi: curren t status of correlation of in vitro data with clinical outcome[J]. J Clin Microbiol, 1996,34:489-495.
  • 3[4] Boken DJ, Swindells S, Riualdl MG. Fluconazole-resistant Candida albic ans[J]. Clin Infect Dis, 1993,17:1018-1021.
  • 4[5] White TC, Marr KA, Bowden RA. Clinical cellular, and molecular factors th at contribute to antifungal drug resistance[J]. Clinical Microbio Rev, 1998,11 :382-402.
  • 5[6] Bostock A, Khattak MN, Mattherws R, et al. Comparison of PCR fingerpr inting, by random amplifcation of polymorphic DNA, with other molecular typing m ethods for Candida albicans[J]. J Gern Micro, 1993,139:2179-2184.
  • 6[7] Robert F, Lebreton F, Bougnoux ME, et al. Use of random amplified pol ymorphic DNA as a typing method for Candida albicans in epidemiological surv eillnace of a burn unit[J]. J Clin Microbio, 1995,33:2366-2371.
  • 7[8] Pujol C, Joly S, Lockhart SR, et al. Parity among the randomly amplif ied polymorphic DNA method, multilocus enzyme electrophoresis, and southern blot hybridization with moderately repetitive DNA probe Ca3 for fingerprinting Can dida albicans[J]. J Clin Microboiol, 1997,35:2348-2358.
  • 8[11] Barchiesi F, Hollis RJ, McGough DA, et al. DNA subtypes and fluocona zole susceptibilities of Candida albicans isolates from the oral earities of patients with AIDS[J]. Clin Infect Dis, 1995,20:634-640.
  • 9[12] Merz WG. Candida albicans albicans strain delineation[J]. Clin Mic robilo Rev, 1990,3:321-334.
  • 10[13] Williams JG, Kubelik AR, Livak KJ, et al. DNA polymorphisms amplifie d by arbitrary primers are useful as genetic markers[J]. Nucl Acids Rev, 1990, 18:6531-6535.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部